Min Tu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 24
- Pancreatic and Hepatic Oncology Research 16
- Cancer-related Molecular Pathways 4
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 3
Min Tu
40 papers receiving 921 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 321
- Oncology 391
- Immunology 160
- Molecular Biology 486
- Surgery 157
Countries citing papers authored by Min Tu
This map shows the geographic impact of Min Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Tu more than expected).
Fields of papers citing papers by Min Tu
This network shows the impact of papers produced by Min Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Tu. The network helps show where Min Tu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 23 | |
| 4 | 2022 | 54 | |
| 5 | 2020 | 59 | |
| 6 | 2018 | 16 | |
| 7 | 2018 | 57 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 24 | |
| 10 | 2016 | 10 | |
| 11 | 2016 | 14 | |
| 12 | 2014 | 75 | |
| 13 | 2014 | 70 | |
| 14 | 2014 | 12 | |
| 15 | 2013 | 49 | |
| 16 | 2013 | 7 | |
| 17 | 2012 | 4 | |
| 18 | 2012 | 20 | |
| 19 | 2012 | 28 | |
| 20 | 2012 | 92 |
About Min Tu
Min Tu is a scholar working on Oncology, Cancer Research, Genetics, Immunology and Cell Biology, having authored 43 papers that have together received 928 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Pancreatitis Pathology and Treatment (6 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers), Phagocytosis and Immune Regulation (4 papers), Congenital heart defects research (3 papers), Microtubule and mitosis dynamics (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (321 citations), Oncology (391 citations), Immunology (160 citations), Molecular Biology (486 citations) and Surgery (157 citations). Min Tu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yi Miao, Jishu Wei, Kuirong Jiang, Zipeng Lu, Wentao Gao, Yunpeng Peng, Jian‐Min Chen, Qiang Li, Junli Wu and Xiaofeng Xue. Their work appears in journals such as Cancer Letters, Oncology Reports, BMC Cancer, Cell Communication and Signaling and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.